Empower Advisory Group, LLC
Position in VRTX — Vertex Pharmaceuticals Inc / Ma
CIK 1978885
Greenwood Village, CO
Position in VRTX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$258,796
+$14,986 QoQ
Shares Held
521
-4.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1,293
of 1,735 holders
Holding Since
Mar 2023
14 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Empower Advisory Group, LLC holds $509,651 across 2 Biotechnology names. VRTX ranks #1 (50.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
521 | $258,796 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
3,205 | $250,855 |
All Filings in VRTX
Export CSV
14 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $258,796 | 521 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $243,810 | 546 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $252,974 | 558 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $229,892 | 587 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $244,414 | 549 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $307,860 | 635 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $266,587 | 662 | Shares | Sole | 2025-01-31 | |
| 2024-09-30 | $286,024 | 615 | Shares | Sole | 2024-11-05 | |
| 2024-06-30 | $293,418 | 626 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $249,551 | 597 | Shares | Sole | 2024-05-02 | |
| 2023-12-31 | $254,306 | 625 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $216,642 | 623 | Shares | Sole | 2023-11-06 | |
| 2023-06-30 | $241,762 | 687 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $231,261 | 734 | Shares | Sole | 2023-05-25 | |
| No filing history on record for this holder in this stock. | ||||||